Scope Fluidics S.A. (WSE:SCP)
144.40
+0.80 (0.56%)
At close: Dec 15, 2025
Scope Fluidics Revenue
Scope Fluidics had revenue of 22.00K PLN in the quarter ending September 30, 2025, a decrease of -8.33%. This brings the company's revenue in the last twelve months to 718.00K, up 503.36% year-over-year. In the year 2024, Scope Fluidics had annual revenue of 131.00K, down -74.61%.
Revenue (ttm)
718.00K
Revenue Growth
+503.36%
P/S Ratio
633.65
Revenue / Employee
5.44K
Employees
63
Market Cap
454.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 585.57M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |